コンテンツへスキップ
Merck
  • Detection of Heteroplasmic Variants in the Mitochondrial Genome through Massive Parallel Sequencing.

Detection of Heteroplasmic Variants in the Mitochondrial Genome through Massive Parallel Sequencing.

Bio-protocol (2019-07-05)
Joke Mertens, Filippo Zambelli, Dorien Daneels, Ben Caljon, Karen Sermon, Claudia Spits
要旨

Detecting heteroplasmies in the mitochondrial DNA (mtDNA) has been a challenge for many years. In the past, Sanger sequencing was the main option to perform this analysis, however, this method could not detect low frequency heteroplasmies. Massive Parallel Sequencing (MPS) provides the opportunity to study the mtDNA in depth, but a controlled pipeline is necessary to reliably retrieve and quantify the low frequency variants. It has been shown that differences in methods can significantly affect the number and frequency of the retrieved variants. In this protocol, we present a method involving both wet lab and bioinformatics that allows identifying and quantifying single nucleotide variants in the full mtDNA sequence, down to a heteroplasmic load of 1.5%. For this, we set up a PCR-based amplification of the mtDNA, followed by MPS using Illumina chemistry, and variant calling with two different algorithms, mtDNA server and Mutect. The PCR amplification is used to enrich the mitochondrial fraction, while the bioinformatic processing with two algorithms is used to discriminate the true heteroplasmies from background noise. The protocol described here allows for deep sequencing of the mitochondrial DNA in bulk DNA samples as well as single cells (both large cells such as human oocytes, and small-sized single cells such as human embryonic stem cells) with minor modifications to the protocol.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
トリシン, BioXtra, pH 4.0-6.0 (1 M in H2O), ≥99% (titration)